Clinical Advances in Hematology and Oncology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023: commentary
Clin Adv Hematol Oncol. 2023 Dec;21 Suppl 6(12):15-17.NO ABSTRACTPMID:38307621 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Bradley A McGregor Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):1-17.NO ABSTRACTPMID:38307618 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer: commentary
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):13-16.NO ABSTRACTPMID:38307619 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Edward B Garon Source Type: research

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023
Clin Adv Hematol Oncol. 2023 Dec;21 Suppl 6(12):1-20.NO ABSTRACTPMID:38307620 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Source Type: research

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023: commentary
Clin Adv Hematol Oncol. 2023 Dec;21 Suppl 6(12):15-17.NO ABSTRACTPMID:38307621 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Bradley A McGregor Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):1-17.NO ABSTRACTPMID:38307618 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer: commentary
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):13-16.NO ABSTRACTPMID:38307619 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Edward B Garon Source Type: research

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023
Clin Adv Hematol Oncol. 2023 Dec;21 Suppl 6(12):1-20.NO ABSTRACTPMID:38307620 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Source Type: research

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023: commentary
Clin Adv Hematol Oncol. 2023 Dec;21 Suppl 6(12):15-17.NO ABSTRACTPMID:38307621 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Bradley A McGregor Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):1-17.NO ABSTRACTPMID:38307618 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer: commentary
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):13-16.NO ABSTRACTPMID:38307619 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Edward B Garon Source Type: research

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023
Clin Adv Hematol Oncol. 2023 Dec;21 Suppl 6(12):1-20.NO ABSTRACTPMID:38307620 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Source Type: research

Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023: commentary
Clin Adv Hematol Oncol. 2023 Dec;21 Suppl 6(12):15-17.NO ABSTRACTPMID:38307621 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Bradley A McGregor Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):1-17.NO ABSTRACTPMID:38307618 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Source Type: research

Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer: commentary
Clin Adv Hematol Oncol. 2023 Oct;21 Suppl 5(10):13-16.NO ABSTRACTPMID:38307619 (Source: Clinical Advances in Hematology and Oncology)
Source: Clinical Advances in Hematology and Oncology - February 2, 2024 Category: Cancer & Oncology Authors: Edward B Garon Source Type: research